Cytovation is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway. The company is currently developing CyPep-1 for the treatment of benign skin tumours including cutaneous warts bit.ly/2K9XFOR

Research has been published in @NatureNews that reinforces the mechanism of action of Cytovation’s peptides #cancer go.nature.com/2HStv1i

Common skin papillomas or warts are a widespread problem which can be debilitating for some bit.ly/1Sbc3mx

Cytovation's product pipeline is focused on tackling common dermatological diseases which have a debilitating impact bit.ly/2dxSoTm

Cytovation chairman Per Eystein Lønning has published a new paper in Cancer Cell bit.ly/2ibWfK6

'Norwegian researchers with new breast cancer breakthrough' - via VG News Norway bit.ly/2vILdRi

Overview of the Human Papillomavirus (HPV) associated cancer (oncology) pipeline landscape read.bi/2ykB937

Cytovation chairman Per Eystein Lønning has published a paper in Cancer Cell bit.ly/2ibWfK6

Cytovation's product pipeline is focused on tackling common dermatological diseases which have a debilitating impact bit.ly/2dxSoTm

Cytovation completes NOK 30m financing round to progress CyPep-H1 through Phase I/IIa clinical study in cutaneous warts bit.ly/2qEVhu6

'Cytovation has raised over €3M to finish off pre-clinical testing of its treatment for warts, and to take it into the clinic' - via Labiotech.eu bit.ly/2AFj3WG

Cytovation has completed a NOK 30m financing round to progress CyPep-H1 through Phase I/IIa clinical study in cutaneous warts bit.ly/2qEVhu6

'Cytovation completes financing round of 30 million NOK' - via Nordic Life Science bit.ly/2D4UnNw

Wart is that! Never mind, cytoVation got rid of it 😎 - #HPV #biotech goo.gl/5sYQAP

Pleased to be featured in Scrip, Citeline Commercial as an emerging company, having raised funds to support initial clinical studies of our potential first-in-class viralytic & oncolytic peptide: 'Cytovation identifies unique peptide for treatment of Cutaneous warts’ 🔒 bit.ly/2tQwrt4

We featured in Scrip, Citeline Commercial as an emerging company, having raised funds to support clinical studies of our potential first-in-class viralytic & oncolytic peptide CyPep: 'Cytovation identifies unique peptide for treatment of Cutaneous warts’ 🔒 bit.ly/2tQwrt4

'NHS crackdown on OTC prescribing' for treatments including warts bit.ly/2GzM3CZ

'NHS England publishes guidelines curbing OTC prescriptions' - via PharmaTimes bit.ly/2uSYOr9

New research published in @NatureNews reinforces the mechanism of action of Cytovation’s peptides #cancer go.nature.com/2HStv1i

New research has been published in @NatureNews that reinforces the mechanism of action of Cytovation’s peptides #cancer go.nature.com/2HStv1i